IP Library › Granted Patent US 9,308,206
Granted Patent B2
US 9,308,206 · App. 14/164,459 · Granted Apr 12, 2016

Compositions and methods for treating colon cancer

Inventors: Satish K Srivastava (Galveston, TX); Kota V Ramana (Galveston, TX)
Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
A61K31/517A61K31/195A61K31/4188A61K31/426A61K31/4747A61K31/502C12Q1/26C12Y101/01021G01N33/5735G01N33/57419C12N15/1137C12N2310/14G01N2500/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,308,206
App. No.
14/164,459
Granted
Apr 12, 2016
Kind
B2
Abstract

Certain embodiments are directed to methods of treating a pathophysiological state or symptoms thereof resulting from aldose reductase-mediated signaling in a cytotoxic pathway using an aldose reductase specific inhibitor.

Claims (1)

1. A method of inhibiting colon cancer cell proliferation in a subject having colon cancer which consists of administering a pharmacologically effective amount of fidarestat which is a specific inhibitor of aldose reductase to the subject having colon cancer, wherein colon cancer cell proliferation in said subject is inhibited.

Continuity (8)
Continuation In Part 12586050 · Sep 16, 2009
Continuation In Part 11282801 · Nov 18, 2005
Continuation In Part 14164459
Continuation In Part 11210283 · Aug 23, 2005
Continuation 11478069 · Jun 29, 2006
Provisional Application 60629448 · Nov 19, 2004
Provisional Application 60603725 · Aug 23, 2004
Related Publication 20140206693A1 · Jul 24, 2014